Saluda Medical announced that it closed a $100 million financing to support its novel closed-loop, dose-control ...
Pulse Biosciences (Nasdaq:PLSE) announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback